Creighton University, Phoenix, AZ, USA.
St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:23247096211013215. doi: 10.1177/23247096211013215.
Bronchopleural fistula (BPF) is associated with high morbidity if left untreated. Although rare, the frequency of BPF in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is becoming recognized in medical literature. We present a case of a 64-year-old male with BPF with persistent air leak due to SARS-CoV-2 pneumonia treated with Spiration Valve System endobronchial valve (EBV). An EBV was placed in the right middle lobe with successful cessation of air leak. In conclusion, the use of EBVs for BPF with persistent air leaks in SARS-CoV-2 patients who are poor surgical candidates is effective and safe.
支气管胸膜瘘（BPF）如果不治疗，发病率很高。虽然罕见，但在医学文献中，越来越多的人认识到严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）与 BPF 有关。我们报告了一例 64 岁男性因 SARS-CoV-2 肺炎并发 BPF 和持续漏气的病例，采用 Spiration Valve System 支气管内瓣（EBV）治疗。在右中叶放置一个 EBV，成功地停止了漏气。总之，对于那些不适合手术的 SARS-CoV-2 患者，EBV 治疗持续漏气的 BPF 是有效和安全的。
